What is the primary purpose of this 8-K filing for HCA Healthcare?

The primary purpose of this 8-K filing is to announce the entry into a material definitive agreement related to the issuance of $3 billion in senior notes by HCA Inc., a subsidiary of HCA Healthcare, Inc. It details the terms, maturities, and interest rates of these notes, which are guaranteed by the parent company.

How will this debt issuance impact HCA Healthcare's financial position?

This issuance of $3 billion in senior notes will increase HCA Healthcare's total debt and leverage ratios. While it provides significant capital, potentially for acquisitions, capital expenditures, or refinancing existing debt, it also increases interest expense obligations and financial risk.

What are the key investor protections outlined in the new note agreements?

Investor protections include covenants that limit the company's ability to incur additional secured debt or dispose of significant assets. Additionally, noteholders have the right to demand repurchase of their notes at 101% of the principal amount, plus accrued interest, upon the occurrence of both a qualifying ratings downgrade and certain changes of control, providing an exit mechanism under adverse scenarios.

What are the maturity dates and interest rates for the new senior notes?

The new senior notes have staggered maturities and corresponding interest rates: $1 billion of 4.700% Senior Notes due May 15, 2031; $750 million of 5.000% Senior Notes due May 15, 2033; and $1.25 billion of 5.300% Senior Notes due May 15, 2036. Interest payments are semi-annual, on May 15 and November 15.

HCA 8-K: Material Agreements & Financial Events

Summary

HCA Healthcare, Inc. (HCA) announced through its subsidiary, HCA Inc., the successful completion of a public offering of $3 billion in aggregate principal amount of senior unsecured notes. The offering is comprised of three tranches: $1 billion of 4.700% Senior Notes due 2031, $750 million of 5.000% Senior Notes due 2033, and $1.25 billion of 5.300% Senior Notes due 2036. These notes are guaranteed on a senior unsecured basis by the Parent Guarantor, HCA Healthcare, Inc. This significant debt issuance, registered under a shelf registration statement, will increase HCA's leverage but provides substantial capital. Investors should note the varying interest rates and maturity dates, which reflect market conditions and the company's long-term financing strategy. The company has entered into an underwriting agreement with several major investment banks for this offering, and detailed terms, including covenants, optional redemption, and change of control provisions, are outlined in the respective indentures filed with the SEC.

Key Highlights

1HCA Inc. issued $3 billion in aggregate principal amount of senior unsecured notes across three maturity tranches.
2The notes include $1 billion due 2031 (4.700% coupon), $750 million due 2033 (5.000% coupon), and $1.25 billion due 2036 (5.300% coupon).
3HCA Healthcare, Inc. (Parent Guarantor) provides a full and unconditional guarantee for these senior unsecured notes.
4The issuance was completed on April 30, 2026, and registered under the company's existing shelf registration statement.
5Covenants in the indentures restrict the company's ability to create liens, engage in sale/lease-back transactions, and dispose of substantial assets.
6The notes include provisions for optional redemption by the issuer and a change of control repurchase right for holders under specific conditions (ratings downgrade and change of control).
7The offering was facilitated through an underwriting agreement with Citigroup Global Markets Inc., Barclays Capital Inc., BofA Securities, Inc., and J.P. Morgan Securities LLC.

HCA Healthcare, Inc. 8-K Report, Material Agreement (Apr 30, 2026)

Summary

Key Highlights

Frequently Asked Questions